Related Experiment Video
Updated: May 5, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Medication treatment complexity and adherence in children with CKD
Tom D Blydt-Hansen1, Christopher B Pierce, Yi Cai
1Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Insights
Managing pediatric chronic kidney disease (CKD) is complex. Increased medication frequency, not the number of conditions, was linked to poorer adherence in children with CKD.
Area of Science:
- Pediatric Nephrology
- Chronic Kidney Disease (CKD) Management
- Comorbidity Assessment
Background:
- Pediatric chronic kidney disease (CKD) management is complicated by numerous comorbid conditions.
- Understanding comorbidity prevalence and clustering is crucial for effective treatment strategies in pediatric CKD.
- Assessing medication use provides insights into comorbidity burden and treatment complexity.
Purpose of the Study:
- To determine the prevalence of comorbidities in pediatric CKD patients.
- To analyze the frequency of co-occurring comorbidities based on medication use.
- To investigate the association between clinical/sociodemographic factors and medication patterns in pediatric CKD.
Main Methods:
- Cross-sectional analysis of the Chronic Kidney Disease in Children study.
- Examined medication use by indication, CKD stage, diagnosis, and patient demographics.
- Assessed nonadherence through self-report of missed medications.
Main Results:
- Medication use for CKD comorbidities increased with advanced CKD stage and glomerular disease.
- Identified three medication clusters: glomerular disease, advanced renal tubular dysfunction, and proteinuric complications.
- Nonadherence was associated with higher medication dosing frequency (>2 times/day), not the number of medications.
Conclusions:
- Medical therapy for pediatric CKD is complex, influenced by diagnosis, CKD stage, and medication frequency.
- CKD staging alone does not reliably predict the need for CKD-related medications.
- Reducing medication frequency, not just the number of conditions, may enhance adherence in pediatric CKD patients.
Background And Objectives:
The complexity of CKD management in children is increased by the number of comorbid conditions. This study assessed the prevalence of comorbidities in pediatric CKD and the frequency with which multiple comorbidities present together by assessing prevalent medication use by CKD stage and diagnosis and their association with clinical or sociodemographic factors. The association between number and frequency of dosing of medications prescribed and self-report of nonadherence was also assessed.
Design, Setting, Participants, & Measurements:
In this cross-sectional analysis of the Chronic Kidney Disease in Children study, medication use at study entry grouped by indication was examined by CKD stage, diagnosis, age, race, ethnicity, income, and CKD duration. Multivariate adjusted predictors of medication use and clustering were examined. Nonadherence was assessed by self-report of missed medications in the past 7 days.
Results:
The 558 eligible participants had a median age of 11 years and median GFR of 44 ml/min per 1.73 m(2); 62% of participants were male and 78% had nonglomerular kidney disease. The number of medications for treatment of CKD comorbidities increased with advanced CKD stage (2.5-fold for stages IV versus II; P<0.001) and glomerular disease (1.4-fold versus nonglomerular; P<0.001). Three distinct medication clusters were identified that corresponded to treatment of glomerular disease, advanced renal tubular dysfunction, and proteinuric complications, respectively. Nonadherence was associated with increased medication dosing frequency (administration >2 times/d; P<0.001) but not the number of medications.
Conclusions:
Medical therapy for children with CKD is complex and is affected by glomerular diagnosis, CKD stage, and medication frequency. The need for CKD-related medication treatment cannot be easily predicted by CKD staging alone. Poorer adherence was associated with increased medication frequency, but not with the number of medical problems needing treatment. Consolidating medical treatment and reducing medication frequency may improve adherence rates in children with CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

